- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
RPG Life Sciences Limited — Updates, 28-01-2026: General Updates
28-01-2026 | 12:02 pm
28-01-2026 | 12:02 pm
RPG Life Sciences Q3 revenue rose 4% to 180 Cr, yet PAT declined 20% to 27.9 Cr. API segment growth was affected by a manufacturing block fire. The company remains debt-free, pursuing strategic initiatives like portfolio expansion and digital transformation.
No comments yet. Be the first to comment!